Cordyceps Sunshine Biotech Holdings (RAJAF) Shares Outstanding (Diluted Average) (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $111.1 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) changed 0.0% year-over-year to $111.1 million; the TTM figure through Dec 2025 stood at $111.1 million (changed 0.0% YoY), while the FY2025 annual figure was $111.1 million, changed 0.0% from the prior year.
• Shares Outstanding (Diluted Average) was $111.1 million for Q4 2025 at Cordyceps Sunshine Biotech Holdings, roughly flat from $111.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $111.1 million in Q4 2023 to a low of $100000.0 in Q4 2021.
• Historically, Shares Outstanding (Diluted Average) has averaged $87.6 million across 5 years, with a median of $111.1 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Diluted Average) tumbled 99.9% in 2021, then surged 104317.53% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $100000.0 in 2021, then soared by 104317.53% to $104.4 million in 2022, then advanced by 6.42% to $111.1 million in 2023, then changed by 0.0% to $111.1 million in 2024, then changed by 0.0% to $111.1 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $111.1 million (Q4 2025), $111.1 million (Q4 2024), and $111.1 million (Q4 2023), per Business Quant data.